Physician
Mehryan, Toufan
Mehryan, Toufan was paid $492K by Medicaid between Apr 2021 and Aug 2023, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoMEHRYAN, TOUFAN
WESTMINSTER, CA 92683
WESTMINSTER, CA 92683
33aNPI1871916841assigned 01/28/2014
33bProvider typeGeneral Practice Physician
28Total paid$492K
24GClaims26,525
24DCodes billed21
24AFirst – last monthApr 2021 – Aug 2023
Compared with peers
Next to other General Practice Physician providers in California
Rank by total paid#52 of 474
Median peer was paid$10K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 7,723 | $133K | |
| 2022 | 15,325 | $275K | |
| 2023 | 3,477 | $84K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 2,092 | 1,874 | $97K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 20% | 1,374 | 1,307 | $96K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18% | 3,437 | 2,843 | $90K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13% | 1,989 | 1,345 | $65K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.6% | 781 | 749 | $42K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 7.1% | 814 | 658 | $35K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.9% | 906 | 771 | $34K |
| 99000 | 2.1% | 3,887 | 3,163 | $10K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 64 | 60 | $5K |
| 99358 | Prolong nursin fac eval 15m | 1.0% | 2,419 | 2,276 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 352 | 339 | $5K |
| 94760 | <1% | 812 | 775 | $3K |
9 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 195 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 212 | $1K |
| 81002 | <1% | 534 | $868.17 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 89 | $501.52 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $322.26 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $74.80 |
| 81000 | <1% | 42 | $61.92 | |
| 99072 | 0% | 3,817 | $0.00 | |
| 99051 | 0% | 2,650 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.